Primary ciliary dyskinesia is an autosomal recessive condition characterised by chronic sinusitis, bronchiectasis, and subfertility. Situs inversus occurs in 50% of cases (Kartagener syndrome). It has an estimated incidence of 1 in 20 000 live births. The clinical phenotype is caused by defective ciliary function associated with a range of ultrastructural abnormalities including absent dynein arms, absent radial spokes, and disturbed ciliary orientation. The molecular genetic basis is unknown. A genome scan was performed in five Arabic families. Using GENEHUNTER, a maximal multipoint lod score (HLOD) of 4.4 was obtained on chromosome 19q13.3-qter at (proportion of linked families) = 0.7. A 15 cM critical region is defined by recombinations at D19S572 and D19S218. These data provide significant evidence for a PCD locus on chromosome 19q and confirm locus heterogeneity. (J Med Genet 2000;37:241-244) 
Primary ciliary dyskinesia (PCD, OMIM 244400) is an autosomal recessive disorder with an estimated incidence of 1 in 20 000 live births. [1] [2] [3] The condition is characterised by recurrent sinopulmonary infections, bronchiectasis, and subfertility. [1] [2] [3] Diagnosis is made by finding abnormal ciliary function on motility studies and abnormal ciliary structure on electron microscopy of brushings or biopsy of nasal mucosa. 2 4 Disease severity varies from mildly aVected subjects to severely disabled patients requiring heart and lung transplantation. [1] [2] [3] The clinical phenotype is caused by dysmotility of the cilia which are complex structures composed of over 200 diVerent polypeptides. 5 6 Cilia are closely related structurally to the flagella of sperm and many protozoa (for example, Chlamydomonas). Microtubule protofilaments are arranged in the axoneme in the well known "9 + 2" pattern ( fig 1) . 7 Adjacent peripheral doublets are connected to each other by nexin links and to the inner pair by radial spokes. The peripheral doublets slide relative to each other in an ATPase dependent reaction involving the outer and inner dynein arms. [8] [9] [10] [11] In humans, ciliated epithelium lines the respiratory tract including the sinuses and middle ear, the ependyma of the brain, the female oviduct, and the male vas deferens. It plays an important role in mucociliary clearance in the respiratory tract. A variety of ultrastructural abnormalities of cilia have been described in PCD. These include absent dynein arms (70-80% of cases), absent radial spokes (5-10%), microtubular transposition, and random ciliary orientation. [12] [13] [14] The molecular genetic basis of PCD is unknown. No gene or locus had been identified although linkage studies have been reported. [15] [16] [17] About half of the patients have defects of laterality, usually situs inversus, a mirror image reversal of the left-right axis (LRA). 18 This association is known as Kartagener syndrome 19 and has been observed with all types of ultrastructural abnormalities except in the so called "microtubular transposition defect" and "overlong cilia". 18 The cooccurrence of ciliary dysfunction with situs inversus indicates that cilia play an important role in this highly conserved and complex pathway of LRA determination. However, the relationship between the ciliary defect and the abnormalities of laterality remains unknown. A number of hypotheses have been proposed, a common feature of which is that the primary defect resides in the cytoskeleton and that both ciliary motility and situs determination are influenced by the cytoskeletal defect. 18 20 21 The only human gene unequivocally associated with situs abnormalities so far is ZIC3, a zinc finger transcription factor, in which mutations have been identified in subjects with X linked and sporadic laterality defects. 22 At present, three genes with a role in ciliary structure or assembly have been implicated in LRA determination: lrd (left-right dynein), hfh-4 (hepatocyte nuclear factor/forkhead homologue 4), and kif3B (kinesin member 3B). [23] [24] [25] We have ascertained an extensive family resource and are undertaking genome searches to identify the genes responsible for PCD. Genetic heterogeneity is anticipated and families have therefore been grouped and analysed initially according to their population of origin or ultrastructural phenotype or both. We present the results of linkage analysis in five families of Arabic origin providing conclusive evidence for a PCD locus on chromosome 19q.
Subjects and methods

FAMILIES
The present report includes data from five families of Arabic origin, four from Saudi Arabia and one from Israel (family 89). DNA was available from a total of 32 subjects (12 aVected, five of whom have situs inversus). The parents in all families are first cousins except in family 72 from Saudi Arabia. Diagnosis of aVected subjects was made according to well established clinical criteria ( Linkage analysis was performed under the assumption of autosomal recessive inheritance with a penetrance of 0.9, disease allele frequency of 0.015, and a phenocopy rate of 0.001. Multipoint analysis was performed using the GENEHUNTER program. 26 The marker loci from chromosome 19q that were included in this analysis were D19S572 -4 cM -D19S418 -3 cM -D19S605 -5 cM -D19S404 -2 cM -D19S214 -1 cM -D19S218. Each marker was assumed to have five alleles of equal frequency. The relative positions of marker loci (fig 2) are based on recently published maps and chromosome 19 specific databases (Lawrence Livermore National Laboratory).
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Results
Over 300 microsatellite markers were typed and excess homozygosity was identified on chromosome 19q. Further analysis of high density mapping data using GENEHUNTER gave a maximum multipoint lod score (HLOD) of 4.4 at D19S404 and D19S218, Discussion This is the first report of the mapping of a locus for primary ciliary dyskinesia. Primary ciliary dyskinesia (PCD) is not an uncommon condition with an estimated incidence of about 1 in 20 000 live births. This is likely to be an underestimation because of the diYculties in making the diagnosis. Some of the clinical features such as otitis media, sinusitis, and recurrent pneumonia are common and are shared with other conditions including cystic fibrosis, immunodeficiency, and asthma. The presence of situs inversus obviously prompts consideration of the diagnosis and allows it to be made more confidently. Confirmation ideally requires nasal brushings/biopsy which is only available at specialised centres and is poorly tolerated by children. Disease severity also varies and some subjects may only manifest very minor or few symptoms. The aVected subjects in our families have been investigated appropriately (table 1) . Investigations to exclude cystic fibrosis and immunodeficiency have been performed in most patients. The presence of bronchiectasis has been documented by x ray or CT scan. All families except 69 have at least one aVected subject with situs inversus. The aVection status can be firmly established on the available evidence from the clinical features and laboratory investigations. The parameters of our linkage analysis are appropriate, assuming a highly penetrant recessive model with a phenocopy rate of 0.001. The disease allele frequency of 0.015 was chosen to correlate with the estimated incidence.
Our data provide conclusive evidence for a PCD locus on chromosome 19q in a subset of these families. Genetic heterogeneity is expected in PCD in view of its wide range of ultrastructural phenotype. Grouping of families according to ultrastructural phenotype or population of origin is therefore a sensible strategy in a disease with expected genetic heterogeneity. All five families are Arabic in origin and aVected subjects have a similar ultrastructural phenotype of absent outer dynein arms. Our linkage data support the presence of genetic heterogeneity of PCD even within these families of common population origin and ultrastructural phenotype. Work is in progress to examine for evidence of linkage in this region in other families/population groups, especially those with absent outer dynein arms.
The gene will be identified using a positional candidate cloning approach. The present 15 cM critical region is defined by recombinations at D19S572 and loss of homozygosity at D19S218 in family 89. This critical region will be further refined by investigation of meioses with flanking recombinants or identification of linkage disequilibrium. The extent of linkage disequilibrium depends on the existence of an ancestral disease mutation, the age of the mutation, and the degree of inbreeding. At present no evidence of linkage disequilibrium has been detected. High density marker typing in the linked families and the rest of the family resource with absent outer dynein arms at this locus is in progress.
Existing knowledge of the biology of cilia and of LRA determination provides a relatively firm foundation for the evaluation of transcripts as potential candidates in this region. Obvious candidates will include genes encoding structural components of cilia (for example, dyneins, tubulins, and microtubule associated proteins). Chromosome 19q13.3-qter is a gene rich region and contains a large cluster of zinc finger containing (ZNF) genes. This is of potential interest as mutations in ZIC3, a zinc finger transcription factor, have been identified in subjects with X linked and sporadic laterality defects. 22 The association of situs inversus with PCD (Kartagener syndrome) remains unexplained. These patients have an increased risk of cardiac malformations which confers significant morbidity. The cloning of lrd, an axonemal dynein heavy chain gene, in the inversus viscerum (iv) mouse support an important role for dyneins in the LRA determination pathway. 23 More recently, work on nodal cilia in mice has provided strong evidence that cilia play a primary role in initiating this process. Nodal cilia are monocilia which are located in the primitive node in the normal embryo. They lack the two central microtubules and therefore adopt the 9 + 0 ultrastructural configuration. They have been shown to be motile and to create a directed flow of extraembryonic fluid which could produce a gradient of putative morphogen along the left-right axis in the node. Mice with targeted disruption of the kinesin family member kif3b gene, which encodes a component of a microtubule plus end directed motor involved in intraciliary transportation, exhibit absence of nodal monocilia and randomisation of left-right asymmetry. 25 It is therefore plausible that any defect producing abnormal cilia including the nodal cilia will result in PCD with randomisation of left-right asymmetry.
Determination of the molecular basis of PCD will provide information relevant both to clinical practice and basic biomedical science. New non-invasive approaches to diagnosis and carrier detection will become available and ultimately new methods of treatment should emerge. Gene therapy, for example, is a feasible long term option in a recessive disorder dominated by respiratory tract pathology. Moreover, it is possible that allelic variation at these loci causes a broader phenotype than presently recognised, including male subfertility or chronic secretory otitis media. The identification of the protein products encoded by PCD genes should provide new insights into the molecular mechanisms involved in the assembly and function of cilia and contribute to understanding of the pathway which determines the left-right axis in vertebrates. Alzheimer's disease currently aVects an estimated 14 million people world wide. As the world population and their longevity increase, it is predicted that this figure will continue to rise rapidly. Cognisant of this "time bomb", scientists across the globe are endeavouring to elucidate the pathogenic mechanisms of the disorder with urgency. Within the past decade, major advances have been made in identifying the genetic causes that result in the abnormal accumulation of beta amyloid, the major component of senile plaques which form one of the neuropathological hallmarks of the disorder.
Dr Tanzi is the Director of the Massachusetts General Hospital's (MGH) Genetics and Aging Unit. With the help of scientific journalist Ann Parson, Dr Tanzi has documented the major discoveries made in the molecular genetics of the disease, including his own work. Most of the book is driven by the amyloid hypothesis, but it does manage to find a little space to mention neurofibrillary tangles and tau mutations, in order not to alienate the "tauists". Those working on beta amyloid are christened "baptists" in the book.
Throughout the book's 12 chapters, Dr Tanzi's personal encounters and achievements are used as the central framework onto which the findings of other laboratories are added, in chronological order. Lucid accounts of the relevant research techniques and molecular biology are provided, with frequent illustrations. These are interspersed with engrossing anecdotes of Dr Tanzi's interactions with the other leaders in the field, including George Glenner, John Hardy, Sam Sisodia, and Dennis Selkoe, which provide an intimate insider's view of the intense, but mostly friendly rivalry which exists between the research groups.
The early chapters describe how the young Dr Tanzi made a solid start to his career by joining James Gusella's laboratory at the MGH in 1980 as a research assistant and playing a significant part in mapping the Huntington's disease gene to chromosome 4. This part of the book also focuses on the isolation of brain amyloid by George Glenner's team, the linkage of the early onset form of the disease to chromosome 21, the hunt for mutations in the amyloid precursor protein gene, and the role of secretases in the processing of beta amyloid.
In the later chapters, the spotlight falls on the presenilins and susceptibility genes in late onset disease, including apolipoprotein E4 and, more controversially, alpha2-macroglobulin, which was proposed by Dr Tanzi himself.
The final couple of chapters oVer hope for patients and carers by enumerating the current therapeutic strategies, including cholinesterase inhibitors, NSAIDs, antioxidants, and cholesterol lowering. Looking towards the future, the potential benefits of beta amyloid vaccines, secretase inhibitors, and metal chelators are mentioned. The protracted and risky process of new drug development is also described.
This book provides a gripping and detailed account of the major advances in the field and we would recommend it to both scientists and clinicians interested in genetics. Lay readers may find themselves lost in the technical details. The book also shows the competitiveness and secrecy resulting from the high stakes involved, which some lay readers may find disconcerting. Overall, we believe that the authors should be commended in writing this book. It is important that the public are reliably informed about progress in medical sciences. This book successfully portrays the major recent advances without suggesting that the problem has been solved.
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Correction
In the paper by Meeks et al on "A locus for primary ciliary dyskinesia maps to chromosome 19q" (J Med Genet 2000;37:241-4), the authors of the paper wish to apologise for an error in fig 1B. This shows a transverse section of a sperm tail rather than a cilium as described in the legend. This was an inadvertent mistake. In view of this, we would like to apologise to the readers of Journal of Medical Genetics and to Dr Afzelius and Harcourt Health Science, as the image had previously been published in Tissue and Cell, vol 27, pp 241-7.
